Blog

SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announces that it is forging ahead with its Measles drug development program.

The Company has commissioned an animal trial to evaluate certain drug candidates in a lethal animal infection model. The Company has secured specially modified mice that bear the human form of CD150/SLAM protein that the Measles virus requires to enter cells. The Company will initiate the study as soon as the animals arrive and are acclimatized at the animal study laboratory.

“NV-387 actually cured lethal RSV infection in animals, and Measles is a cousin of RSV,” said Anil R. Diwan, Ph.D., President and Executive Chairman of the Company, adding, “This gives us confidence that NV-387 will have strong activity against Measles virus as well.”

NV-387 is a clinical stage broad-spectrum antiviral drug that is designed to act as a decoy of a cell, attacking the virus by presenting to it the very features that the virus requires for binding to the cell, and upon binding, destroying the virus particle so it cannot infect. Over 90-95% of human pathogenic viruses require the sulfated proteoglycan feature that NV-387 presents to the virus.

There is no approved drug for the treatment of Measles virus infection. Recently, CDC included Vitamin A as part of the standard of care for Measles infection. Vitamin A is known to help malnourished children with Measles, but its role as supplementary addition to non-deficient patients is not known. CDC also recommended use of ribavirin in extreme cases as a last resort. Ribavirin is a toxic nucleoside analog and is not approved for treatment of Measles.

Thus there is a clear unmet need for a Measles drug. NV-387, a clinical stage drug can be rapidly developed to meet this need. The animal study of effectiveness of NV-387 in h-SLAM-modified mice will provide important information regarding potential human effectiveness of NV-387 to treat Measles virus infection.

Measles outbreaks have continued to expand in the US, reaching a record 1,088 confirmed cases across 33 jurisdictions from January 1 through May 29, 2025 according to CDC (https://www.cdc.gov/measles/data-research/index.html). Europe has witnessed a dramatic ten-fold increase in measles cases last year, i.e. 2024, over 2023.

Measles vaccination rates have been declining in the USA since the COVID pandemic, according to a June 3, 2025 Johns Hopkins University news report (https://hub.jhu.edu/2025/06/03/united-states-measles-vaccination-rate-declines/). The average county-level MMR vaccination rate in the USA fell from 93.92% pre-pandemic to 91.26% post-pandemic, moving well below the 95% herd immunity threshold that is generally regarded as providing community or herd immunity.

Additionally, Measles vaccine failure cases have also been increasing according to the European data, which is an important cause for concern. It is likely that the increase in vaccine failure rate may be due to the increase in a new genotype, D8 of the Measles virus, replacing the previous dominant B3 genotype. The B3 genotype is closer to the Measles vaccine live attenuated Enders-Edmonton “Moraten” strain that has been used in the USA since 1968.

The changing genotypes suggest that the Measles virus is likely drifting away from the current vaccine.

In this global scenario, NV-387, the clinical stage broad-spectrum, host-mimetic antiviral nanomedicine drug could perhaps be the only currently available drug candidate to combat the Measles virus and disease.

Measles cases in Europe were over 35,000 in 2024, an almost ten-fold increase from 2023, according to the annual report of European Center for Disease Prevention and Control (ECDC). Only approximately 87% of cases were in unvaccinated persons, and 13% of the cases were of vaccine failure, out of the cases with known vaccination status.

The significant Measles vaccine failure rate observed in Europe is alarming, considering that the two-dose vaccine is supposed to be 97% effective. Overall, childhood vaccination in Europe was about 94% and declining. This rate is below the 95% considered the threshold for achieving “herd” or community immunity.

Given the various causes of vaccine failure, and of vaccine hesitancy, attaining 95% vaccine coverage cannot be considered a very probable solution for combating the Measles epidemic. An effective drug is needed to combat the epidemic.

ABOUT NANOVIRICIDES
NanoViricides, Inc. (the “Company”) (www.nanoviricides.com) is a publicly traded (NYSE-American, stock symbol NNVC) clinical stage company that is creating special purpose nanomaterials for antiviral therapy. The Company’s novel nanoviricide™ class of drug candidates and the nanoviricide™ technology are based on intellectual property, technology and proprietary know-how of TheraCour Pharma, Inc. The Company has a Memorandum of Understanding with TheraCour for the development of drugs based on these technologies for all antiviral infections. The MoU does not include cancer and similar diseases that may have viral origin but require different kinds of treatments.
The Company has obtained broad, exclusive, sub-licensable, field licenses to drugs developed in several licensed fields from TheraCour Pharma, Inc. The Company’s business model is based on licensing technology from TheraCour Pharma Inc. for specific application verticals of specific viruses, as established at its foundation in 2005.

Our lead drug candidate is NV-387, a broad-spectrum antiviral drug that we plan to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections, as well as MPOX/Smallpox infections. Our other advanced drug candidate is NV-HHV-1 for the treatment of Shingles. The Company cannot project an exact date for filing an IND for any of its drugs because of dependence on a number of external collaborators and consultants. The Company is currently focused on advancing NV-387 into Phase II human clinical trials.

The Company is also developing drugs against a number of viral diseases including oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. NanoViricides’ platform technology and programs are based on the TheraCour® nanomedicine technology of TheraCour, which TheraCour licenses from AllExcel. NanoViricides holds a worldwide exclusive perpetual license to this technology for several drugs with specific targeting mechanisms in perpetuity for the treatment of the following human viral diseases: Human Immunodeficiency Virus (HIV/AIDS), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Rabies, Herpes Simplex Virus (HSV-1 and HSV-2), Varicella-Zoster Virus (VZV), Influenza and Asian Bird Flu Virus, Dengue viruses, Japanese Encephalitis virus, West Nile Virus, Ebola/Marburg viruses, and certain Coronaviruses. The Company intends to obtain a license for RSV, Poxviruses, and/or Enteroviruses if the initial research is successful. As is customary, the Company must state the risk factor that the path to typical drug development of any pharmaceutical product is extremely lengthy and requires substantial capital. As with any drug development efforts by any company, there can be no assurance at this time that any of the Company’s pharmaceutical candidates would show sufficient effectiveness and safety for human clinical development. Further, there can be no assurance at this time that successful results against coronavirus in our lab will lead to successful clinical trials or a successful pharmaceutical product.

This press release contains forward-looking statements that reflect the Company’s current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company’s expectations include, but are not limited to, those factors that are disclosed under the heading “Risk Factors” and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities. Although it is not possible to predict or identify all such factors, they may include the following: demonstration and proof of principle in preclinical trials that a nanoviricide is safe and effective; successful development of our product candidates; our ability to seek and obtain regulatory approvals, including with respect to the indications we are seeking; the successful commercialization of our product candidates; and market acceptance of our products.

The phrases “safety”, “effectiveness” and equivalent phrases as used in this press release refer to research findings including clinical trials as the customary research usage and do not indicate evaluation of safety or effectiveness by the US FDA.

FDA refers to US Food and Drug Administration. IND application refers to “Investigational New Drug” application. cGMP refers to current Good Manufacturing Practices. CMC refers to “Chemistry, Manufacture, and Controls”. CHMP refers to the Committee for Medicinal Products for Human Use, which is the European Medicines Agency’s (EMA) committee responsible for human medicines. API stands for “Active Pharmaceutical Ingredient”. WHO is the World Health Organization. R&D refers to Research and Development.

Contact:

NanoViricides, Inc.

info@nanoviricides.com

Public Relations Contact:

ir@nanoviricides.com

SOURCE: NanoViricides

View the original press release on ACCESS Newswire

DUBLIN, IE / ACCESS Newswire / June 4, 2025 / Undefeated Irish boxer turned US Billboard Charting and multi-platinum artist Marc Mysterio (3-0, 2 KOs as pro) – his 2006-2009 BoxRec profile application pending – and 10-0-1 amateur standout under the late Gregory Leschishin of USA Boxing – tragically killed last month by a carjacker, according to Yahoo – resumes his world title quest with a clean bill of health after a 15+ year hiatus from the sport.

Following a preliminary mutual understanding, Marc Mysterio is set to face the WBC’s 18th-ranked Serhiy Radchenko (11-8-0, 5 KOs) on Oct. 12, 2025, in “Irish Pride vs. Ukrainian Glory: Marc Mysterio v. Radchenko,” promoter Ville Ruutu of World Class Promotions (WCP) confirmed Wednesday. “WBC Ukraine President Mykola Kovalchuk played a key role in facilitating this mutual understanding, as shown by his initial WhatsApp response, ‘I think Radchenko should take the fight,’ and we remain grateful for his support.”

A 2009 basketball injury paused Mysterio’s boxing, sparking a music career with hits alongside David Guetta, Avicii, Samantha Fox, Crash Test Dummies and Flo Rida, including “The Dancefloor” which entered the U.S. Billboard charts, plus TMZ, Radar Online, and Perez Hilton buzz, Miami Herald and Boston Globe coverage, and “Trailer Park Boys” fame culminating in 81,000,000+ streams from 15,000,000 listeners during September 2023-September 2024, resulting in over 1,250,000+ Fans and 15,000+ Super Fans on Amazon Music.

Last year, he challenged Jake Paul to replace semi-retired opponent Ryan Bourland with himself in a February bout in Puerto Rico – backed by the IBA’s former chairman who volunteered to sanction the proposed bout for their vacant super cruiserweight intercontinental championship – covered by the UK’s Daily Express and The Irish Star, with Mysterio even posting read-receipts of his team’s emails to Nakisa Biderian of MVP Promotions on his X account, @marc_mysterio.

“I’m back to finish what I started,” Mysterio declared. “On Oct. 12, every Irish fan must join this pilgrimage – Ukrainians will rally for Radchenko. It’s Irish pride versus Ukrainian glory!”

2010 WBC Trainer of the Year Gabriel Sarmiento has recently been working with Mysterio in the months prior to Coach Greg’s death, and will travel to Ireland for Marc’s pre-fight camp. “Marc’s skill reflects decades of work and has adapted well to my coaching,” Sarmiento said. “He’ll prove that he is both a machine and a legitimate contender – I believe Marc will dominate Radchenko.”

Radchenko, a former WBC silver Bridgerweight champion, has faced undisputed light heavyweight champion Dmitry Bivol and WBC Bridgerweight champion Kevin Lerena in May 2025. “I fight for Ukraine’s glory – Slava Ukraini!” Radchenko has stated previously, translated from Ukrainian, reflecting his enduring inspiration.

Jill Diamond, WBC secretary and WBC Cares global chairwoman, was quoted by the UK’s Daily Express last year, “Marc Mysterio is a force in music and boxing and, moreover, a friend of the WBC and WBC Cares. We support his efforts.”

“At present, I look forward to donating a portion of my purse to WBC Cares, as well as tickets to the event for local disabled children,” Mysterio notes, confirming his support of the charitable organization and youth.

“Speaking personally, not for the DFA or Irish government, Marc inspires Ireland by blending boxing, music, and philanthropy, overcoming countless obstacles after his injury and the recent loss of his lifelong coach – embodying the essence of Irish pride in my view,” said David Costello, an Irish diplomat and former head of mission to several countries.

“On May 26, at the request of WBC Ukraine President Mykola Kovalchuk, we sent a letter to WBC President Mauricio Sulaiman seeking sanctioning for the Mysterio-Radchenko bout as a ranked fight under WBC rules, including proof of a venue hold for Oct. 12 at one of Europe’s top 10 indoor arenas by 2024 ticket sales, as required for sanctioning,” Ville Ruutu said. “With Irish and Ukrainian fans competing for scarce tickets, broadcasters like Netflix, ESPN, ESPN+, DAZN and Sky Sports are vying for exclusive rights – possibly drawn by Marc’s ESPN ‘First Take’ tie, when Stephen A. Smith chose ‘Be The Truth’ for the show in 2016, and Netflix ‘Trailer Park Boys’ connection. This will influence our decision, though not decisively. We’ll prioritize the networks’ coverage of this landmark bout from now to early July over financial incentives, aiming for the best long-term outcome for both fighters and the Bridgerweight division. Broadcast partners will be revealed at the mid-July press conference.”

The official venue, pre-sale ticket date, broadcast partners and event sponsors unveil will occur at a mid-July press conference at which WCP anticipates, in light of both boxers statements, the live appearances of both warriors – as well as the official contract signing to formalize the bout – at a location, date and time to be announced in an early July press release.

“I’ll fight Radchenko on Oct. 12, with or without WBC sanctioning as a ranked fight. Defeating the 18th-ranked boxer – who entered May 2025 as silver champion – basically guarantees me a top-25 WBC Bridgerweight world ranking – sanctioning should be a mere formality of that result! This is a professional 10-round fight, three-minute rounds, no matter what! I am also volunteering to enter the WBC Clean Program aimed at eradicating PEDs from the sport, required for top 15 rankings in WBC. Finally, I aim to pioneer Bridgerweight, like Holyfield did for cruiserweight, a division ripe with talent, but lacking prestige to casual fans before his charismatic championship reign that paved the road for guys like Usyk, a friend of Radchenko – It all starts Oct. 12 – I just wish that Coach Greg was still here to witness it,” Mysterio concludes.

Those wishing to obtain media credentials for the press conference and/or interactive livestream should immediately provide their credentials to the media contact listed below.

About Marc Mysterio

Irish-Canadian undefeated boxer (3-0, 2 KOs) turned multi-platinum artist, with 81 million Amazon Music streams and 15 million listeners (September 2023-September 2024), now fully recovered from injury to resume his career, trained by Gabriel Sarmiento. Mysterio supports WBC Cares, One Fund Boston, and International Red Cross.

About Serhiy Radchenko

Ukrainian former WBC silver Bridgerweight champion, Radchenko supports WBC Cares and Ukraine’s frontline defenders.

About Gabriel Sarmiento

Argentine trainer Gabriel Sarmiento, named 2010 WBC Trainer of the Year, guided Sergio Martinez to world championships in two weight classes: the WBC super welterweight title (2009-2010) and the unified WBC, WBO, Ring magazine, and lineal middleweight titles (2010-2014). He also trained Kiko Martinez, a two-division world champion, capturing the super bantamweight title (2013-2014) and featherweight title (2021-2022). In addition to Marc Mysterio, Sarmiento currently trains undefeated Polish cruiserweight phenom Michał Soczyński (10-0, 7 KOs).

About World Class Promotions

Irish-rooted World Class Promotions delivers premier boxing events, blending sport and philanthropy to support WBC Cares and elevate divisions like Bridgerweight (200-224 lbs), recognized by WBC and WBA.

Media Contact

Ville Ruutu
World Class Promotions (WCP)
pr@shadowban.me

Resources

• Marc Mysterio career bio

• Marc Mysterio featured in Billboard

• Marc Mysterio 2025 press photo

• Marc Mysterio boxing promotion photo

• Daily Express feature: Marc Mysterio vs. Jake Paul, January 2024

• Irish Star feature: Marc Mysterio vs. Jake Paul, January 2024

• Marc Mysterio 81MM+ Streams/Listeners on Amazon Music

• Marc Mysterio September 2023-2024 Fans/Super Fans on Amazon Music

• IFPI Gold Certification for Marc Mysterio & Trailer Park Boys

• Marc Mysterio on X

• Yahoo article: Gregory Leschishin murder, May 7, 2025

• Bubbles on Marc Mysterio with Trailer Park Boys

• Radar Online Feature on Marc Mysterio (One Fund Boston)

• WBC’s International Secretary and WBC Cares Chairwoman Jill Diamond Letter of Support for Marc Mysterio (2022)

• Serhiy Radchenko BoxRec record

• Radchenko vs. Bivol full match on YouTube

• Radchenko 2025 Press Photo provided courtesy of WBC Ukraine PR Director, Inna Kostiuk

• Radchenko on Instagram

• WBC Bridgerweight Rankings (Radchenko still listed as ‘Silver Champion’ but was stripped due to May 1st loss vs World Champion Kevin Lerena according to WBC Ukraine President’s Confirmation via What’sApp)

• Donate to WBC Cares

• IBA Former Chairman’s Official Letter on Marc Mysterio vs. Jake Paul (2024)

-END-

SOURCE: World Class Promotions

View the original press release on ACCESS Newswire

• Proven track record of discovery, resource and production expansion

• Demonstrated success in both the Deseado Massif and the Iberian Pyrite Belt

TORONTO, ON / ACCESS Newswire / June 4, 2025 / Cerrado Gold Inc. (TSXV:CERT)(OTCQX:CRDOF)(FRA:BAI0) (“Cerrado” or the “Company“) is pleased to announce the appointment of Mr. Alonso Lujan to the position of Vice President Exploration effective June 1, 2025. Mr. Lujan has over 34 years of international experience in mineral exploration with a proven track record for discovery, resource and production expansion. After joining Cerrado as a consultant in February 2025, Mr. Lujan has now been appointed Vice President of Exploration.

Most recently Mr. Lujan spent eight years with Sierra Metals (“Sierra”) as Vice President Exploration where he led the significant expansion of the mineral resources across their mines by 25 million ounces of silver and 300 million pounds of copper. As the General Manager for Sierra’s Mexican operations, he successfully expanded production and lowered the All-In-Sustaining-Cost (“AISC”). Prior to Sierra, he spent six years with Matsa-Trafigura as the General Manager where he led the discovery of 50 million tonnes of additional mineral resources in less than two years, and doubled production from 2.2 to 4.6 million tonnes per year, which led to the growth in value of the operation from US$300 million to US$1.6 billion. Prior to that, he worked with Hochschild Mining and Minas de Bacis SA de CV, in the Deseado Massiff, where his exploration and operational expertise led to increased production.

Mark Brennan, Executive Chairman, commented: “On behalf of the Board and Management teams, I would like to welcome Alonso to the team. He is a proven professional with a strong history of finding and expanding mineral resources and increasing production output. His experience in the Deseado Massif has provided a new perspective for a well planned and solid exploration program for the current 20,000 metre drill program about to begin at Minera Don Nicolas. The primary objective of the drill program is to add additional resources to extend the mine life at MDN. Additionally, his strong experience and record while working in the Iberian Pyrite Bet, will benefit the Company by potentially assisting in increasing the resource base and improving output as we continue to advance and develop the Lagoa Salgada VMS project.”

About Cerrado

Cerrado Gold is a Toronto-based gold production, development, and exploration company. The Company is the 100% owner of the gold producing Minera Don Nicolás and Las Calandrias mine in Santa Cruz province, Argentina. In Portugal, the Company holds an 80% interest in the highly prospective Lagoa Salgada VMS project through its position in Redcorp – Empreendimentos Mineiros, Lda. In Canada, Cerrado Gold is developing its 100% owned Mont Sorcier high purity Iron oreb project located outside of Chibougamou, Quebec.

In Argentina, Cerrado is maximizing the asset value at its Minera Don Nicolas operation through continued operational optimization, cost reductions and is growing production through its operations at the Las Calandrias heap leach project. An extensive campaign of exploration is ongoing to further unlock potential resources in our highly prospective land package in the heart of the Deseado Masiff.

In Portugal, Cerrado is focused on the development of the highly prospective Lagoa Salgada VMS project located on the prolific Iberian Pyrite Belt in Portugal. The Lagoa Salgada project is a high-grade – low cost, polymetallic project, demonstrating a typical mineralization endowment of zinc, copper, lead, tin, silver, and gold. Extensive exploration upside potential lies both near deposit and at prospective step-out targets across the large 7,209-hectare property concession. Located just 80km from Lisbon and surrounded by exceptional infrastructure, Lagoa Salgada offers a low-cost entry to a significant exploration and development opportunity, already showing its mineable scale and cashflow generation potential.

In Canada, Cerrado holds a 100% interest in the Mont Sorcier Iron project, which has the potential to produce a high quality premium iron concentrate over a long mine life at low operating costs and low capital intensity. Furthermore, its high grade and high purity product facilitates the migration of steel producers from blast furnaces to electric arc furnaces, contributing to the decarbonization of the industry and the achievement of sustainable development goals.

For more information about Cerrado please visit our website at: www.cerradogold.com.

Mark Brennan
CEO and Chairman

Mike McAllister
Vice President, Investor Relations
Tel: +1-647-805-5662
mmcallister@cerradogold.com

Disclaimer

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

This press release contains statements that constitute “forward-looking information” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that discusses predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. There is no assurance that the exploratory drill program will be successful or that any additional resources exist or will be discovered.

Forward-looking statements contained in this press release include, without limitation, statements regarding the business and operations of Cerrado.

SOURCE: Cerrado Gold Inc.

View the original press release on ACCESS Newswire

Initial implementations have delivered 35% accuracy improvement and 10% reduction in product returns

SAN FRANCISCO, CA / ACCESS Newswire / June 4, 2025 / Sama, the leader in purpose-built, responsible enterprise AI with agile data labeling for model training and performance evaluation, today announced the launch of Sama Multimodal, a new solution that combines multiple data types and inputs with human-in-the-loop (HITL) validation to create more powerful, accurate AI systems. By integrating diverse modalities including images, video, text, audio, LiDAR and radar data, Sama Multimodal has demonstrated significant improvements in model accuracy for industries such as automotive and retail. Early results have been impressive, including a large retail implementation that saw a 35% increase in model accuracy and a 10% reduction in product returns.

Sama Multimodal offers enterprise AI teams a flexible framework and its widget-based architecture makes it easy to rapidly integrate multiple AI models at different stages of workflow, including using pre-annotations from open source, client and/or Sama-based models, while incorporating strategic HITL validation – ensuring quality and mitigating bias in model outputs.

“With Sama Multimodal, organizations can build differentiated AI solutions using the full spectrum of data available, including sensor data which is growing ever more prolific,” said Duncan Curtis, SVP of AI Product and Technology at Sama. “What makes our platform truly unique is its flexibility – teams can ingest, align, and annotate any combination of modalities, then transition from pre-trained to proprietary models at the right moment in their development workflow. It’s designed to evolve with AI itself.”

Sama Multimodal democratizes access to advanced AI technologies and creates differentiated customer experiences for the retail and automotive industries. In retail applications, for example, Sama’s multimodal capabilities significantly improve search relevance applications and product discovery with a combination of image, text, and video annotations. In automotive, Sama Multimodal excels at integrating camera, LiDAR, and radar data to create more comprehensive environmental understanding for advanced driver assistance systems and autonomous vehicles.

Sama’s multimodal infrastructure is future-proof, enabling enterprises to scale model sophistication without rebuilding data pipelines from scratch. By leveraging human expertise for complex contextual understanding while automating routine data processing tasks, Sama Multimodal is ideal not only for today’s applications but also for emerging needs, such as voice-assisted retail search, vision-enhanced robotics, and personalized customer experiences powered by real-time behavioral data.

Sama Multimodal is fully supported by SamaHub™, a collaborative workspace and by SamaAssure™, the industry’s highest quality guarantee, which routinely delivers a 98% first batch acceptance rate.

About Sama

Sama is a global leader in data annotation solutions for computer vision, generative AI and large language models. Our solutions minimize the risk of model failure and lower the total cost of ownership through an enterprise ready ML-powered platform and SamaIQ™, actionable data insights uncovered by proprietary algorithms and a highly skilled on-staff team of over 5,000 data experts. 40% of FAANG companies and other major Fortune 50 enterprises, including GM, Ford and Microsoft, trust Sama to help deliver industry-leading ML models.

Driven by a mission to expand opportunities for underserved individuals through the digital economy, Sama is a certified B-Corp and has helped more than 68,000 people lift themselves out of poverty. An MIT-led Randomized Controlled Trial has validated its training and employment program. For more information, visit www.sama.com.

Sama Media Contact:

press@samasource.org

SOURCE: Sama

View the original press release on ACCESS Newswire

LONDON, UNITED KINGDOM / ACCESS Newswire / June 4, 2025 / Alpha Growth Plc, a leading financial services company in the life insurance-linked asset/wealth management business, is pleased to provide the following update for its group company, Alpha Growth Management LLC.

Alpha Growth Management LLC, a specialist in esoteric and longevity-based investments, announces a performance and strategy update for the Alpha Alternative Assets Fund (Nasdaq: I Shares – AAACX and A Shares – AACAX) since the firm assumed management in September 2022.

Strategic Transition and Investment Focus
In September 2022, Alpha Growth Management LLC took over as investment adviser for AAAF, implementing a new strategy centered on longevity and esoteric assets. The fund now targets structured settlement receivables, legal finance, life settlements, royalties, and other unconventional assets designed to deliver low correlation to traditional markets and offer unique risk premiums. This approach leverages Alpha Growth’s extensive expertise in sourcing and managing assets that are typically inaccessible to most investors with limited quarterly liquidity through the interval fund structure.

Performance Overview: September 2022 – May 2025

• Trailing twelve months (1 year) as of 5/31/2025: AAAF continued its positive momentum, posting a 7.44% net return.

• 2024: AAAF continued its positive momentum, posting a 5.85% return year-to-date as of December 31, 2024. This performance outpaced its benchmark, which returned 3.60% during the same period.

• 2023: The fund achieved a positive annual return of 1.99% for the full year 2023, marking a turnaround from prior declines and reflecting early benefits of the revised investment approach.

• 2022 (Post-Transition Partial Year): Following the management change, AAAF returned -1.24% for the period ending September 30, 2022, outperforming the Bloomberg Barclays Global Aggregate Index, which returned -5.14% in the same period.

Key Differentiators and Portfolio Construction

• Dual-Strategy Approach: AAAF employs a dual-sleeve structure, balancing illiquid longevity assets with a liquid sleeve to manage cash flow and provide quarterly repurchase offers.

• Diversification and Risk Management: The fund’s portfolio is constructed to minimize correlation with traditional equity and bond markets, offering investors potential refuge from broader market volatility.

• Quarterly Liquidity: As an interval fund, AAAF provides quarterly repurchase offers, allowing investors periodic access to liquidity while maintaining exposure to less liquid, potential higher-yielding assets.

Industry Context

AAAF’s recent performance demonstrates the potential of alternative strategies to deliver value in a challenging and evolving investment environment. The fund’s focus on longevity and esoteric assets positions it within the interval fund landscape, providing access to asset classes traditionally reserved for institutional investors.

About Alpha Growth Management LLC
Alpha Growth Management LLC is a US-registered investment adviser specializing in alternative investment strategies, with a focus on esoteric and longevity assets. The firm is committed to delivering innovative portfolio solutions that provide diversification and enhanced return opportunities for investors.

For more information on Alpha Alternative Assets Fund, please visit https://funds.alphagrowthmgt.com/

Alpha Growth plc	+44 (0) 20 3959 8600
Gobind Sahney, Executive Chairman	info@algwplc.com
UK Investor Relations – Mark Treharne	ir@algwplc.com

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets and insurance linked asset and wealth management. Building on its well-established network, the Alpha Growth group has a unique position in the insurance and asset services and investment business, as a listed entity with global reach. The group’s strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialized skills and unique access to deploy their financial resource in longevity assets.

Longevity Assets and Non-correlation

As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.

Important Disclosures

THIS IS NEITHER AN OFFER TO SELL NOR A SOLICITATION TO PURCHASE ANY SECURITY. INVESTORS SHOULD CAREFULLY CONSIDER THE INVESTMENT OBJECTIVES, RISKS, CHARGES AND EXPENSES OF THE ALPHA ALTERNATIVE ASSETS FUND.

IMPORTANT RISK INFORMATION: Investing in esoteric assets involves unique risks, distinct from those associated with traditional asset classes. These risks may include, but are not limited to, liquidity risk, market risk, regulatory risk, and valuation risk. Investors should be aware that the value of esoteric assets may fluctuate, and there is a possibility of partial or total loss of investment. Investors should be aware that these assets may not align with traditional risk models, leading to increased volatility and heightened sensitivity to external factors. Before engaging in esoteric asset investments, it is advisable for investors to thoroughly understand the associated risks, seek professional guidance, and stay informed about market developments. Due diligence is crucial, as thorough research and expert advice are essential to navigating the complexities associated with esoteric assets. Past performance is not indicative of future results, and the unique characteristics of esoteric assets require careful consideration and a well-informed investment strategy.

Investing in the Fund’s shares involves risks, including the following: The Fund’s shares have limited pricing or performance history. Shares of the Fund will not be listed on any securities exchange, which makes them inherently illiquid. There is no secondary market for the Fund’s shares, and it is not anticipated that a secondary market will develop. The shares of the Fund are not redeemable. Although the Fund will offer to repurchase at least 5% of outstanding shares on a quarterly basis in accordance with the Fund’s repurchase policy, the Fund will not be required to repurchase shares at a shareholder’s option nor will shares be exchangeable for units, interests or shares of any security. The Fund is not required to extend, and shareholders should not expect the Fund’s Board of Trustees to authorize, repurchase offers in excess of 5% of outstanding shares. Regardless of how the Fund performs, an investor may not be able to sell or otherwise liquidate his or her shares whenever such investor would prefer and, except to the extent permitted under the quarterly repurchase offer, will be unable to reduce his or her exposure on any market downturn. If and to the extent that a public trading market ever develops, shares of closed-end investment companies, such as the Fund, may have a tendency to trade frequently at a discount from their NAV per share and initial offering prices. An investment in the Fund’s shares is not suitable for investors who cannot tolerate risk of loss or who require liquidity, other than liquidity provided through the Fund’s repurchase policy. Alternative investments are highly speculative and involve a great degree of risk and are not suitable for all investors. Full loss of principal is possible. The fund may engage in the use of leverage and other speculative investment practices, such as short sales, options, derivatives, futures and illiquid investments that may increase the risk of investment loss. Investment return and principal value will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than original cost.

IMPORTANT DEFINITIONS: Esoteric Assets: Esoteric Assets refer to debts or other financial instruments with a complex structure that is properly understood by only a few people with specialized knowledge.

Litigation Finance, also known as third-party litigation funding, is a financial arrangement where a third party provides capital to a plaintiff or defendant in a lawsuit, in exchange for a share of any resulting settlement or judgment.

Correlation refers to the degree to which the price of a particular asset or investment moves to the overall stock market.

A Life Settlement is the sale of an existing life insurance policy to a third party for a lump-sum payment, typically more than the policy’s cash surrender value but less than the death benefit. The buyer becomes the new policy owner and beneficiary.

Structured Settlements are legal settlements paid out as an annuity rather than in a lump sum, usually with certain tax advantages for the recipient and savings for the payer.

A Royalty Deal is an agreement where someone receives a payment, typically a percentage of revenue or a fixed amount per unit, for the use of their property, intellectual property, or assets.

SPE or Special Purpose Entity, is a legal entity (often a limited company) created to fulfill specific or temporary objectives, often used to isolate financial risks or manage specific asset.

Non-Bid: A contract awarded or executed without seeking bids or proposals from any other potential bidder or offerer.

Non Flow: Unlike equities that may pay out no cash flows to investors, or variable-income securities, where payments can change based on some underlying measure, such as short-term interest rates, the payments of a fixed-income security are known in advance and remain fixed throughout.

Non-Market:: Not relating to or influenced by the demand of people to buy certain things or the supply of things to be purchased.

Non-Auctioned: Do not participate in a formal auction for the securities but instead accept the market price set by other participants.

Non-Brokered:: A company sells the security directly to investors. By doing this, the company can forgo the fees and hassle of hiring a broker (often an investment bank) and maintains more control over the selling process.

Alpha: Alpha is used in finance as a measure of performance, indicating when a strategy, trader, or portfolio manager has managed to beat the market return or other benchmark over some period.

DIVERSIFICATION DOES NOT GUARANTEE AGAINST A LOSS.

BEFORE INVESTING YOU SHOULD CAREFULLY CONSIDER THE FUND’S INVESTMENT OBJECTIVES, RISKS, CHARGES AND EXPENSES. THIS AND OTHER INFORMATION IS IN THE PROSPECTUS, A COPY OF WHICH MAY BE OBTAINED FROM ALPHAGROWTHMGT.COM. PLEASE READ THE PROSPECTUS CAREFULLY BEFORE YOU INVEST.

Distributed by ALPS DISTRIBUTORS INC.

AAA00000155

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Alpha Growth PLC

View the original press release on ACCESS Newswire

NEW YORK CITY, NY / ACCESS Newswire / June 3, 2025 / EquityMultiple, a leading real estate investment platform for accredited investors, recently closed a $3 million co-GP equity investment in the development of Poindexter Southend, a 263-unit Class A multifamily and mixed-use property in the South End neighborhood of Charlotte, North Carolina. Led by seasoned Sponsor Avery Hall Investments, the project will deliver a luxury eight-story residential building with 1,200 square feet of retail, surrounded by vibrant nightlife, retail, and transit access.

The investment took nine days to fund, and is one of the fastest-funded investments in EquityMultiple’s decade-long history. “The strength and experience of the Sponsor coupled with the attractive going-in basis in a great infill location all contributed to the success and speed of the raise,” said Marious Sjulsen, EquityMultiple’s CIO. “The site is shovel-ready, and construction is expected to begin as soon as the loan closes. We are excited to be part of this project with such a strong team.”

The Poindexter Southend project represents an especially timely opportunity for investors. Charlotte remains one of the premier migration destinations in the U.S., with population growth twice the national average since 2010. The city also ranked #2 in U-Haul’s 2024 Migration Report, with an estimated 117 new residents per day, fueling continued housing demand. In the South End of Charlotte, where Poindexter Southend is located, this demand is concentrated among renters seeking walkable, amenity-rich neighborhoods with access to transit and employment hubs. Moreover, as an asset class, multifamily has seen a “flight to quality” after the rapid increase in rents post-COVID.

Since its inception in 2015, and aided by its strategic partnership with Marcus & Millichap beginning in 2023, EquityMultiple has developed a targeted, institutional approach to the real estate crowdfunding concept. Through its nationwide network of over 60,000 self-directed investors, EquityMultiple has provided financing for hundreds of commercial real estate transactions, including Poindexter Southend, and distributes a comprehensive track record to investors containing metrics on all investments dating back to 2015. This year, the platform was selected as the “Best Real Estate Crowdfunding Site for Transparency” by Investopedia. Through its subsidiary EM Investment Partners (EMIP), EquityMultiple has also provided flexible capital markets solutions to dozens of sponsors and operators across the U.S. in various forms: JV equity (LP and co-GP); senior debt; mezzanine and subordinate debt; and preferred equity. The Poindexter Southend project is EquityMultiple’s first collaboration with Avery Hall Investments.

About EquityMultiple

EquityMultiple’s mission is to guide investors toward a stronger, more diversified portfolio. EquityMultiple brings accredited investors curated real estate private equity and private credit opportunities, broadening and streamlining access to CRE. Founded in 2015, EquityMultiple has completed 250 transactions totaling over $21 billion in total capitalization across 142 markets nationwide. For more information, visit equitymultiple.com.

Contact Information

Daniel Brereton
press@equitymultiple.com
+16468449918

SOURCE: Equity Multiple Inc

View the original press release on ACCESS Newswire

LOS ANGELES, CA AND CHICAGO, IL / ACCESS Newswire / June 3, 2025 / Let Music Fill My World, a nonprofit dedicated to enriching children’s lives through music education, is proud to announce its partnership with Parmelee Avenue Elementary School to expand the school’s music program. Through this collaboration, Let Music Fill My World has funded the hiring of a dedicated music teacher starting full-time in July for a three-year period, ensuring that students receive consistent, quality music instruction and opportunities to develop their musical talents.

Let Music Fill My World was introduced to Parmelee Elementary through a referral from last year’s individual winner of the Music Matters Challenge, Jesse Robitalle, who identified the school as being in need of musical support. This connection enabled the nonprofit to bring meaningful musical resources to a deserving community.

Music education has long been underfunded in schools, leaving many students without access to the creative and developmental benefits of learning music. Studies have shown that music education enhances cognitive abilities, improves academic performance, and fosters social and emotional growth. Music education is also correlated with a range of 21st-century skills, such as critical thinking, creativity, innovation and collaboration. Unfortunately, budget constraints have led to the reduction or elimination of music programs in many schools, particularly in under-resourced communities.

Let Music Fill My World is actively working to change this reality. By partnering with schools like Parmelee Avenue Elementary and hosting the Music Matters Challenge, they are ensuring that students receive the music education they deserve. The newly hired music teacher will help students imagine what is possible through the imagination and creative thinking sparked in the classroom.

In his recent book The Life Impossible, Matt Haig spotlighted music: “She explained her love of music to me. ‘It makes the world bigger, she said […] ‘I feel like I am trapped in a box sometimes and when I am playing piano or singing, I break out of that box for a while. Music to me is like a friend that comes in just when you need it.”

According to Cayley Tull, co-founder of Let Music Fill My World and president of the Tullman Family Office, music education unlocks more than meaningful connection. “Academic and technical skills alone are not enough to prepare our youth for the demands of the 21st-century workplace. Regular access to high-quality music and arts education expands the tools students need to succeed in school, work and life.”

“Feeling music is a powerful force that allows you to dream. A full-time music teacher will empower our Parmelee Scholars to believe, achieve and set goals for the future,” says Principal Ferguson, Principal of Parmelee.

“I had the chance to sing for the students at Parmelee last Christmas, and their energy and spirit were unforgettable,” says Jesse Robitaille, the 2024 winner of the Music Matters Challenge. “As an under-resourced school, every child there deserves the chance to grow through music, and I’m honored this grant will help make that possible. Thank you, LMFMW, for investing in their future.”

The expansion of Parmelee Avenue Elementary’s music program is just one of many initiatives Let Music Fill My World is undertaking to bring the magic of music to more students. The nonprofit continues to seek new partnerships and funding opportunities to support music education in schools across the country.

For more information about Let Music Fill My World and its initiatives, please visit https://letmusicfillmyworld.com/.

###

ABOUT LET MUSIC FILL MY WORLD:

“Let Music Fill My World” was born in 2023 when Tullman Family Office (TFO) teamed up with Grammy-nominated artist John Ondrasik of Five For Fighting to empower students at Farragut Career Academy in Chicago. Ondrasik and eight students co-wrote the song, with the students contributing the lyrics, passionately expressing their personal connection to music. Despite evidence showing that music programs boost test scores, reduce disciplinary issues, and improve graduation rates, arts education continues to face cuts in lower-income urban schools, often being the first to go during budget constraints. “Let Music Fill My World” is on a mission to change that, supporting sustainable music funding and changing lives in the process.

ABOUT FIVE FOR FIGHTING / JOHN ONDRASIK:

In the two decades since Five for Fighting’s first major single, “Superman (It’s Not Easy),” hit the stratosphere, Five For Fighting (aka John Ondrasik), has released six studio LPs, including the platinum-certified “America Town” and “The Battle for Everything;” and the top-10 charting “Two Lights,” along with an EP and live albums. A post 9-11 anthem, Ondrasik performed “Superman (It’s Not Easy),” at the 2001 Concert for New York, a benefit show at Madison Square Garden that honored first responders and the fallen about a month after the tragic September 11th attacks. Ondrasik has penned major hits, including the chart-topping “100 Years,” “The Riddle,” “Chances,” “World,” and “Easy Tonight,” which have earned tens of millions of streams and placed him as a top-10 Hot Adult Contemporary artist for the 2000s. The reflective “100 Years” has joined “Superman (It’s Not Easy)” as part of the American Songbook and continues to stand the test of time. Five For Fighting’s music has also been featured in more than 350 films, television shows, and commercials, including the Oscar-winning “The Blind Side,” “Hawaii Five-O,” “The Sopranos,” and the CBS drama, “Code Black.” For more information visit: www.fiveforfighting.com.

ABOUT THE TULLMAN FAMILY OFFICE:

The Tullman Family Office (TFO) directs the Chicago-based Tullman family’s philanthropy, political advocacy, business investments focused on social impact, and community engagement initiatives. We partner with visionary leaders, grassroots organizations, and creative thinkers to move beyond incremental progress – reimagining resources, accelerating impact, and activating collective solutions that advance equity and opportunity for all. For more information about TFO’s philanthropic work, visit: https://www.tullmanfamilyoffice.org/

PUBLICITY CONTACTS

Cassie Zebisch-Schienle | cassie@cmzpr.com
Abbey Kovacevich | abbey@cmzpr.com

SOURCE: Let Music Fill My World

View the original press release on ACCESS Newswire

NEW YORK, NY / ACCESS Newswire / June 3, 2025 / On May 30, 2025, Wintergreen Acquisition Corp. (NASDAQ:WTGUU) (“Wintergreen” or the “Company”) announced the closing of its initial public offering of 5,595,000 units. This includes 595,000 units issued pursuant to the underwriter’s partial exercise of its over-allotment option, which also closed today, May 30, 2025. The offering was priced at $10.00 per unit, resulting in gross proceeds of $55,950,000.

Wintergreen’s units are listed on the Nasdaq Capital Market (“NASDAQ”) and began trading under the ticker symbol “WTGUU” on May 29, 2025. Each unit consists of one ordinary share, par value $0.0001 per share, and one right entitling the holder thereof to receive one-eighth (1/8) of one ordinary share upon consummation of an initial business combination. Once the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be listed on NASDAQ under the symbols “WTG” and “WTGUR,” respectively.

Of the proceeds received from the consummation of the initial public offering (including the partial exercise of the over-allotment option) and a simultaneous private placement of 253,875 placement units to the Company’s sponsor, MACRO DREAM Holdings Limited, for an aggregate purchase price of $2,538,750, a total of $56,089,875 (or $10.025 per public unit) was placed into a trust account in the United States at Wilmington Trust, National Association.

The Company intends to use the net proceeds from the offering to acquire a business focused on the technology, media, and telecommunications industries. Its search for a target business will focus on companies with operations or prospective operations in the Asia Pacific region, including the Greater China region, that have advanced and highly differentiated solutions.

D. Boral Capital LLC acted as sole book-running manager in the offering.

Concord & Sage P.C. served as U.S. legal counsel to Wintergreen on the initial public offering, and Ogier served as Cayman Islands legal counsel to Wintergreen. Robinson & Cole LLP served as legal counsel to D. Boral Capital LLC.

A registration statement on Form S-1 (File No. 333-286795) relating to these securities has been filed with the Securities and Exchange Commission (“SEC”), and was declared effective on May 28, 2025.

The offering was made by means of a prospectus. Copies of the prospectus may be obtained from D. Boral Capital LLC, 590 Madison Avenue, 39th Floor, New York, NY 10022, by phone at +1 (212) 970 5150 or emailing info@dboralcapital.com. Copies of the registration statement can also be obtained by visiting EDGAR on the SEC’s website at www.sec.gov.

No Offer

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Wintergreen Acquisition Corp.

Wintergreen Acquisition Corp. is a newly incorporated blank check company incorporated as a Cayman Islands exempted company (company number 409590) for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. Its search for a target business will focus on companies with operations or prospective operations in the Asia Pacific region, including the Greater China region, that have advanced and highly differentiated solutions.

About D. Boral Capital

D. Boral Capital LLC is a premier, relationship-driven global investment bank headquartered in New York. The firm is dedicated to delivering exceptional strategic advisory and tailored financial solutions to middle-market and emerging growth companies. With a proven track record, D. Boral Capital provides expert guidance to clients across diverse sectors worldwide, leveraging access to capital from key markets, including the United States, Asia, Europe, the Middle East, and Latin America.

A recognized leader on Wall Street, D. Boral Capital has successfully aggregated approximately $30 billion in capital since its inception in 2020, executing ~350 transactions across a broad range of investment banking products.

Forward-Looking Statement

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the prospectus and the Company’s other filings with the SEC. The Company undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

For more information, please contact:

D. Boral Capital LLC
Email: info@dboralcapital.com
Telephone: +1(212)-970-5150

SOURCE: D. Boral Capital LLC

View the original press release on ACCESS Newswire

AI Innovation, Entrepreneurial Culture, M&A Growth, and Operational Excellence Fuel 2025 Recognition

PLANO, TEXAS / ACCESS Newswire / June 3, 2025 / Think Power Solutions, a leading provider of AI-enabled utility infrastructure solutions, proudly announces its fifth consecutive Great Place to Work® Certification™, highlighting its exemplary commitment to fostering a safe, entrepreneurial, and empowering work environment.

“This recognition, for the fifth consecutive year, is especially meaningful because it’s based entirely on feedback from our teams,” said Hari Vasudevan, PE, Founder & CEO of Think Power Solutions. “At Think Power, we believe that when we take care of our people, they care for our customers and investors. As we continue to grow both organically and through targeted acquisitions, we remain focused on driving AI-powered innovation, strengthening customer relationships, and fostering a workplace culture that sets the standard for safety and excellence in the utility industry.”

Driving Organic Growth and M&A Strategy

As part of its long-term strategy, Think Power Solutions continues to seek partnerships with entrepreneur/family-led firms specializing in utility infrastructure services that drive America’s electric utility resilience, reliability, and smarter capital investment. Focus areas include:

• Advisory services

• Engineering services

• Project management

• Specialized field services

• Software solutions

Through strategic M&A, the company aims to scale nationally, generate operational synergies, and accelerate industry-wide AI innovation to better serve its clients.

“We couldn’t be prouder of the positive response we received from our employees. This is a testament to our employee-centric culture that binds us together. We’re excited to drive further growth in the utility sector and will continue to improve our workplace culture. Think Power Solutions continues to attract top talent and deliver industry-leading utility infrastructure services,” said David Chandler, CHRO, Think Power Solutions.

Think Power fosters a culture where employees are empowered, connected, and driven by purpose. This commitment is reflected in key survey results: nearly 90% of employees express strong pride in their work and believe customers would rate Think Power’s service as “excellent.” These insights reinforce the company’s people-first philosophy and reputation for delivering high-performance, client-focused solutions.

About Think Power Solutions

Think Power Solutions is a leading provider of AI-enabled utility infrastructure solutions. The company partners with many of the nation’s largest investor-owned and cooperative utilities. Known for its operational excellence, innovative technology, and industry-leading safety record, Think Power has earned a reputation as a trusted partner in the utility sector. The company actively engages in key industry organizations, including the Edison Electric Institute (EEI), and maintains a strong client-focused approach. With a culture rooted in innovation, excellence, and employee engagement, Think Power continues to attract top-tier talent and deliver solutions that support the evolving needs of the utility industry.

Learn more at www.thinkpowersolutions.com. Follow us on LinkedIn, Twitter, and Facebook.

About Great Place To Work®

As the global authority on workplace culture, Great Place To Work® brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Their proprietary platform and For All™ Model helps companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified™ or receiving recognition on a coveted Best Workplaces™ List.

Media Contact:
Sayantan Dasgupta
Director, Marketing – Brand & Content
sayantan.dasgupta@thinkpowersolutions.com

SOURCE: Think Power Solutions

View the original press release on ACCESS Newswire